BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2741)

  • 1. Proceedings: An investigation of the rat in situ absorption model using practolol and propranolol.
    Taylor DC; Grundy RU
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():65P. PubMed ID: 2741
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption of practolol and propranolol in dog intestinal loops in situ [proceedings].
    Taylor DC; Grundy RU; Loveday BE
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():51P. PubMed ID: 22683
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Overflow of (14C)-practolol and (14C)-racemic propranolol from the isolated rat vas deferens.
    Lewis MJ; Graham JD
    Br J Pharmacol; 1974 Sep; 52(1):125P. PubMed ID: 4451780
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption of propranolol and practolol in Coeliac disease.
    Parsons RL; Kaye CM; Raymond K; Trounce JR; Turner P
    Gut; 1976 Feb; 17(2):139-43. PubMed ID: 1261884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
    Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol absorption in different regions of the rat gastrointestinal tract in situ: implications for sustained release formulations.
    Taylor DC; Grundy R
    J Pharm Pharmacol; 1980 Jul; 32(7):499-500. PubMed ID: 6105188
    [No Abstract]   [Full Text] [Related]  

  • 8. Local anesthesia: the interaction between phospholipids and chlorpromazine, propranolol, and practolol.
    Lee AG
    Mol Pharmacol; 1977 May; 13(3):474-87. PubMed ID: 17828
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.
    Hayes A; Cooper RG
    J Pharmacol Exp Ther; 1971 Feb; 176(2):302-11. PubMed ID: 4998689
    [No Abstract]   [Full Text] [Related]  

  • 10. Theoretical Michaelis-Menten elimination model for propranolol.
    McAinsh J; Gay MA
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):241-5. PubMed ID: 4085525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro detection of possible in vivo drug interactions. Part 1. The effect of hydrochlorothiazide and frusemide on the in vitro absorption characteristics of propranolol hydrochloride.
    Anber SA; Al-Janabi II; Mustafa RM; Razzo FN
    Pharmazie; 1981 Jun; 36(6):425-7. PubMed ID: 7279990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interactions between anti-arrhythmic agents, antacids and antidiarrheals. IV. Procainamide and propranolol: adsorption on antacids and antidiarrheals and the effect of these latter on in vitro absorption].
    Remon JP; Van Severen R; Braeckman P
    Pharm Acta Helv; 1981; 56(9-10):257-61. PubMed ID: 7291209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Elimination of practolol in uremia].
    Wierzchowiecki M; Michałowska D; Tomaszkiewicz T; Maćkowiak M; Ochotny R
    Wiad Lek; 1980 May; 33(9):677-81. PubMed ID: 7405235
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism studies with practolol [proceedings].
    Case DE; Lindup WE; Lowery C; Orton TC; Reeves PR; Whittaker SE
    Br J Pharmacol; 1978 Jun; 63(2):352P. PubMed ID: 96899
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of acute alcohol administration on propranolol absorption.
    Grabowski BS; Cady WJ; Young WW; Emery JF
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):317-9. PubMed ID: 7429677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    Evans GH; Nies AS; Shand DG
    J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution kinetics and intestinal absorption of practolol in the rat.
    Barber HE; Bourne GR
    Br J Pharmacol; 1971 Mar; 41(3):513-20. PubMed ID: 4396971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal absorption of hawthorn flavonoids--in vitro, in situ and in vivo correlations.
    Zuo Z; Zhang L; Zhou L; Chang Q; Chow M
    Life Sci; 2006 Nov; 79(26):2455-62. PubMed ID: 16989871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.
    Branch RA; Nies AS; Shand DG
    Drug Metab Dispos; 1973; 1(5):687-90. PubMed ID: 4149707
    [No Abstract]   [Full Text] [Related]  

  • 20. The application of clearance concepts to propranolol disposition in man.
    Wilkinson GR
    Drug Metab Rev; 1979; 10(1):107-23. PubMed ID: 393480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.